Nuveen LLC Invests $26.90 Million in Privia Health Group, Inc. $PRVA

Nuveen LLC purchased a new position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,198,163 shares of the company's stock, valued at approximately $26,899,000. Nuveen LLC owned about 0.99% of Privia Health Group as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Bessemer Group Inc. increased its stake in Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after purchasing an additional 2,178 shares during the last quarter. Janney Montgomery Scott LLC increased its stake in Privia Health Group by 4.6% in the first quarter. Janney Montgomery Scott LLC now owns 55,371 shares of the company's stock valued at $1,243,000 after purchasing an additional 2,413 shares during the last quarter. GAMMA Investing LLC increased its stake in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after purchasing an additional 1,521 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Privia Health Group by 10.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock valued at $27,687,000 after purchasing an additional 138,747 shares during the last quarter. Finally, Teacher Retirement System of Texas acquired a new position in Privia Health Group in the first quarter valued at $387,000. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Stock Up 2.3%

Shares of NASDAQ PRVA traded up $0.4850 on Friday, hitting $21.8150. The company had a trading volume of 132,505 shares, compared to its average volume of 840,075. Privia Health Group, Inc. has a 12-month low of $16.47 and a 12-month high of $26.09. The business has a 50 day moving average of $20.95 and a two-hundred day moving average of $22.71. The firm has a market capitalization of $2.68 billion, a P/E ratio of 198.38, a PEG ratio of 3.07 and a beta of 0.80.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The company had revenue of $521.15 million during the quarter, compared to analysts' expectations of $466.97 million. During the same period in the previous year, the company earned $0.19 EPS. Privia Health Group's quarterly revenue was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently commented on PRVA. Piper Sandler dropped their target price on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a research note on Monday, August 11th. Zacks Research upgraded Privia Health Group from a "strong sell" rating to a "hold" rating in a research note on Tuesday. JPMorgan Chase & Co. upped their target price on Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, May 28th. Barclays upped their target price on Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 27th. Finally, JMP Securities reissued a "market outperform" rating and set a $29.00 price target on shares of Privia Health Group in a research report on Monday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $28.00.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.